Not applicableStudy completedNCT05727436What this trial is testingThe Effect of Probiotics on GingivitisWho this might be right forGingivitis; Chronic I.M. Sechenov First Moscow State Medical University 61
Not applicableStudy completedNCT06938165What this trial is testingThe Safety and Efficacy of Fecal Microbiota Transplant (FMT) for Steroid-refractory Graft-versus-host DiseaseWho this might be right forGVHD Nanfang Hospital, Southern Medical University 46
Not applicableStudy completedNCT01468051What this trial is testingTwo Schedules of Hepatitis B Vaccination in Predialysis Chronic Renal Failure PatientsWho this might be right forRenal Failure Tehran University of Medical Sciences 51
Large-scale testing (Phase 3)Active Not RecruitingNCT05515029What this trial is testingPreventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Calcineurin Inhibitor at Patients With HemoblastosisWho this might be right forAcute Lymphoblastic LeukemiaMyeloblastic LeukemiaBiphenotypic Acute Leukemia+3 more Federal Research Institute of Pediatric Hematology, Oncology and Immunology 56
Not applicableEnded earlyNCT02115971What this trial is testingJumping Exercises Approach in Individuals With Chronic Ankle InstabilityWho this might be right forJoint InstabilityChronic DiseaseSprains Swanenburg 10
Not applicableActive Not RecruitingNCT04231500What this trial is testingThe Skin Microbiome in Graft Versus Host DiseaseWho this might be right forSkin MicrobiomeGraft Versus Host DiseaseGraft Versus Host Disease in Skin University Hospital, Basel, Switzerland 74
Not applicableStudy completedNCT05169411What this trial is testingPreserving Kidney Function in Children With Chronic Kidney DiseaseWho this might be right forChronic Kidney Disease Stage 2Chronic Kidney Disease Stage 3Pediatric Kidney Disease Children's Hospital of Philadelphia 20,240
Testing effectiveness (Phase 2)UnknownNCT04969172What this trial is testingA Phase II Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Exosomes Overexpressing CD24 to Prevent Clinical Deterioration in Patients With Moderate or Severe COVID-19 InfectionWho this might be right forCOVID-19 Disease Eli Sprecher, MD 155
Testing effectiveness (Phase 2)Study completedNCT01273207What this trial is testingExtension Study (Extended Access) of Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients for the Treatment of Bronchiolitis ObliteransWho this might be right forBronchiolitis ObliteransConstructive BronchiolitisGraft Versus Host Disease+3 more National Heart, Lung, and Blood Institute (NHLBI) 7
Testing effectiveness (Phase 2)UnknownNCT00447460What this trial is testingTreatment of Refractory (Acute or Chronic) Graft-Versus-Host Disease by the Infusion of Expanded in-Vitro Allogenic Mesenchymal Stem CellWho this might be right forGraft-vs-Host Disease (GVHD) University of Salamanca 15
Large-scale testing (Phase 3)Study completedNCT02336230What this trial is testingA Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)Who this might be right forGrade B aGVHDGrade C aGVHDGrade D aGVHD Mesoblast, Inc. 55
Testing effectiveness (Phase 2)UnknownNCT03771222What this trial is testingProphylactic Donor Lymphocyte Infusion After Allo-PBSCT for Patients With Very High-risk Hematologic MalignanciesWho this might be right forDonor Lymphocyte InfusionPeripheral Blood Stem Cell TransplantationRelapse+2 more Chinese PLA General Hospital 40
Not applicableUnknownNCT00948519What this trial is testingLaser Assisted Treatment of Chronic Sinusitis With and Without Light Activated AgentsWho this might be right forRhinosinusitis New York Head & Neck Institute 40
Testing effectiveness (Phase 2)Study completedNCT01844765What this trial is testingOpen Label, Phase II Study to Evaluate Efficacy and Safety of Oral Nilotinib in Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia (CML) Pediatric Patients.Who this might be right forPhiladelphia Positive (Ph+) Chronic Myelogenous Leukemia Novartis Pharmaceuticals 59
Testing effectiveness (Phase 2)WithdrawnNCT01882387What this trial is testingEfficacy Study of a TXA127 to Reduce Graft-vs-Host Disease in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell TransplantationWho this might be right forHematologic Malignancies Tarix Pharmaceuticals
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07381114What this trial is testingA Clinical Study on the Efficacy and Safety of Ivarmacitinib in Preventing aGVHD After HLA-matched TransplantationWho this might be right foraGVHD Institute of Hematology & Blood Diseases Hospital, China 32
Testing effectiveness (Phase 2)Ended earlyNCT01453140What this trial is testingIn-vivo Regulatory T Cell Enhancement With Cyclophosphamide and SirolimusWho this might be right forGraft Versus Host Disease Hackensack Meridian Health 3
Testing effectiveness (Phase 2)Study completedNCT00078858What this trial is testingMycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell TransplantWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+132 more Fred Hutchinson Cancer Center 37
Not applicableUnknownNCT03880214What this trial is testingPrevalence of Chronic Oral Graft Versus Host Disease Risk Factors in Pediatric PatientsWho this might be right forOral DiseaseGraft-versus-host-diseaseStem Cell Transplant Complications+1 more yasmeen magdi sholkamy 250
Testing effectiveness (Phase 2)Study completedNCT00002833What this trial is testingPeripheral Stem Cell Transplantation Plus Filgrastim in Treating Patients With Acute or Chronic Myelogenous LeukemiaWho this might be right forGraft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes M.D. Anderson Cancer Center 53